For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.
Wirelessly enabled devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.
Wirelessly Enabled Injection Devices - What You Will Learn
- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs? - What benefits do wirelessly enabled drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication? - What therapeutic areas are the current focus of wirelessly enabled devices? - Who are the companies behind the growth of wirelessly enabled injection devices? What are their development activities and corporate alliances and affiliations - What is the importance of pharma-device alliances and design partnerships on wirelessly enabled drug injection device commercialization and market access? - What does the current market for wirelessly enabled drug injection devices look like? What will it look like in 2022? - What are the key market drivers for the growth of wirelessly enabled injection devices?
Key Topics Covered:
1. Executive Summary
2. Wireless Injection Devices - The Opportunity
3. Injectable Device Technology
- Market Drivers - The Growth of Self-Administration - The Rise in Home Healthcare - The Cost of Non-Adherence - Biological Injectables and Patient Safety - The Impact of Developing Economies
4. Connectivity Technologies
- Wireless Technologies - Bluetooth - Cellular - Near Field Communications - RFID
5. Wirelessly Enabled Device Classes
- Wearable Devices - Handheld Devices - Device Segments - Non-drug Specific Connected Injectors - Automated Connected Injectors - Vendor-specific Connectivity Platforms - Third Party Connectivity Devices
6. Near-term Markets for Connected Injection Devices